Smith Anglin Financial, LLC
- SEC CIK
- 0001553540
- Latest filing
- Jul 17, 2025
ABT holding history
Abbott Laboratories in every 13F filed by Smith Anglin Financial, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2025 holdings
- Shares (Q2 2025)
- 3,002
- Value
- $408.2K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 3,002 | $408.2K | <0.1% | +13+0.4% | Added | Holders |
| Q1 2025 | 2,989 | $396.4K | <0.1% | +44+1.5% | Added | Holders |
| Q4 2024 | 2,945 | $333.1K | <0.1% | −281−8.7% | Reduced | Holders |
| Q3 2024 | 3,226 | $367.8K | <0.1% | −330−9.3% | Reduced | Holders |
| Q2 2024 | 3,556 | $369.5K | <0.1% | −159−4.3% | Reduced | Holders |
| Q1 2024 | 3,715 | $422.2K | <0.1% | +202+5.8% | Added | Holders |
| Q4 2023 | 3,513 | $386.6K | <0.1% | −1,329−27.4% | Reduced | Holders |
| Q3 2023 | 4,842 | $468.9K | 0.1% | +12+0.2% | Added | Holders |
| Q2 2023 | 4,830 | $526.6K | 0.1% | −82−1.7% | Reduced | Holders |
| Q1 2023 | 4,912 | $497.4K | 0.1% | +242+5.2% | Added | Holders |
| Q4 2022 | 4,670 | $512.7K | 0.1% | +11+0.2% | Added | Holders |
| Q3 2022 | 4,659 | $451.0K | 0.1% | −14−0.3% | Reduced | Holders |
| Q2 2022 | 4,673 | $508.0K | 0.1% | −207−4.2% | Reduced | Holders |
| Q1 2022 | 4,880 | $578.0K | 0.1% | +192+4.1% | Added | Holders |
| Q4 2021 | 4,688 | $660.0K | 0.1% | +2,143+84.2% | Added | Holders |
| Q3 2021 | 2,545 | $301.0K | 0.1% | −4−0.2% | Reduced | Holders |
| Q2 2021 | 2,549 | $295.0K | 0.1% | −8−0.3% | Reduced | Holders |
| Q1 2021 | 2,557 | $306.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.